Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67
United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Sean Maduck
3 Nov 2026
See Remarks
Sold after exercise
4,542
$82.68
$375.51K
Sean Maduck
3 Nov 2026
See Remarks
Sold after exercise
8,617
$82.02
$706.76K
Roberto Wandenkolk Vieira
2 Nov 2026
President, Oncology
Sold after exercise
1,676
$81.52
$136.63K
Roberto Wandenkolk Vieira
2 Nov 2026
President, Oncology
Sold after exercise
6,657
$80.73
$537.44K
Sean Maduck
2 Nov 2026
See Remarks
Sold after exercise
11,841
$81.42
$964.07K
James N Wilson
15 Oct 2026
Director
Sold on a plan indirect
300
$116.30
$34.89K
James N Wilson
15 Oct 2026
Director
Sold on a plan indirect
3,046
$115.39
$351.48K
James N Wilson
15 Oct 2026
Director
Sold on a plan indirect
6,654
$114.48
$761.72K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 33,333
History held since 3 Oct 2006